• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.深入探究 CYP3A 睾酮代谢:CYP3A4/5 和 CYP3A7 的动力学、区域选择性和立体选择性差异。
Drug Metab Dispos. 2017 Dec;45(12):1266-1275. doi: 10.1124/dmd.117.078055. Epub 2017 Oct 6.
2
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.细胞色素 P4503A 亚家族介导的甾体激素羟化作用比较。
Arch Biochem Biophys. 2020 Mar 30;682:108283. doi: 10.1016/j.abb.2020.108283. Epub 2020 Jan 27.
3
Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity.重组和微粒体 CYP3A 酶中去氧胆酸的立体选择性氧化动力学:去氧胆酸 19-羟化是 CYP3A7 活性的体外标志物。
Drug Metab Dispos. 2019 Jun;47(6):574-581. doi: 10.1124/dmd.119.086637. Epub 2019 Mar 27.
4
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.细胞色素P450 3A4、细胞色素P450 3A5和细胞色素P450 3A7的比较代谢能力。
Drug Metab Dispos. 2002 Aug;30(8):883-91. doi: 10.1124/dmd.30.8.883.
5
Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies.比较甾体激素和α-萘黄酮对人细胞色素 P4503A 亚家族催化的甾体激素羟化的刺激和抑制作用。
Biol Pharm Bull. 2021;44(4):579-584. doi: 10.1248/bpb.b20-00987.
6
Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5.比较人细胞色素 P450 3A4 和 3A5 的甾体激素羟化作用和对接。
J Pharm Pharm Sci. 2019;22(1):332-339. doi: 10.18433/jpps30558.
7
Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.甾体激素和细胞色素 P450(CYP)3A 抑制剂对 CYP3A 亚家族催化的皮质醇 6β-羟化的刺激和抑制作用。
Drug Metab Bioanal Lett. 2023;16(2):73-80. doi: 10.2174/2949681016666230830125358.
8
Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.CYP3A在人肝脏中的表达——CYP3A7和CYP3A4之间的转换在出生后立即发生的证据。
Eur J Biochem. 1997 Jul 15;247(2):625-34. doi: 10.1111/j.1432-1033.1997.00625.x.
9
Variability of CYP3A7 expression in human fetal liver.人胎儿肝脏中CYP3A7表达的变异性。
J Pharmacol Exp Ther. 2005 Aug;314(2):626-35. doi: 10.1124/jpet.105.086504. Epub 2005 Apr 21.
10
Testosterone-metabolizing capacity and characteristics of adrenal microsomes in human fetus in vitro.人胎儿肾上腺微粒体在体外的睾酮代谢能力及特征
J Pediatr Endocrinol Metab. 2010 Jan-Feb;23(1-2):143-52. doi: 10.1515/jpem.2010.23.1-2.143.

引用本文的文献

1
Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions.基于药物代谢酶和转运体功能评估的精准药物治疗。
Precis Clin Med. 2025 Feb 22;8(1):pbaf004. doi: 10.1093/pcmedi/pbaf004. eCollection 2025 Mar.
2
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.前列腺癌:遗传学、当前生物标志物和个体化治疗的综述。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70016. doi: 10.1002/cnr2.70016.
3
Ninjin'yoeito in the Management of Frailty and Overactive Bladder in Elderly Women: A Report of Two Cases.人参养荣汤治疗老年女性虚弱和膀胱过度活动症:两例报告
Cureus. 2024 Sep 13;16(9):e69304. doi: 10.7759/cureus.69304. eCollection 2024 Sep.
4
Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study.2型糖尿病男性睾酮治疗期间铁调素降低:一项随机、双盲、安慰剂对照研究。
Biomedicines. 2023 Nov 29;11(12):3184. doi: 10.3390/biomedicines11123184.
5
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention.靶向卵巢癌中的细胞色素P450酶:肿瘤选择性干预的新方法。
Biomedicines. 2023 Oct 26;11(11):2898. doi: 10.3390/biomedicines11112898.
6
Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.多性状全基因组关联研究确定了一个与睾酮水平相关的新型子宫内膜癌风险位点。
iScience. 2023 Apr 7;26(5):106590. doi: 10.1016/j.isci.2023.106590. eCollection 2023 May 19.
7
The Role of CYP3A in Health and Disease.细胞色素P450 3A在健康与疾病中的作用
Biomedicines. 2022 Oct 24;10(11):2686. doi: 10.3390/biomedicines10112686.
8
Metabolites of Cannabigerol Generated by Human Cytochrome P450s Are Bioactive.大麻萜酚的人体细胞色素 P450 代谢物具有生物活性。
Biochemistry. 2022 Nov 1;61(21):2398-2408. doi: 10.1021/acs.biochem.2c00383. Epub 2022 Oct 12.
9
Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.使用高通量筛选平台鉴定选择性CYP3A7和CYP3A4底物及抑制剂
Front Pharmacol. 2022 Jul 1;13:899536. doi: 10.3389/fphar.2022.899536. eCollection 2022.
10
Sex-dependent metabolism of ketamine and ()-hydroxynorketamine in mice and humans.在小鼠和人体内,()-羟基去甲氯胺酮和氯胺酮的性别依赖性代谢。
J Psychopharmacol. 2022 Feb;36(2):170-182. doi: 10.1177/02698811211064922. Epub 2021 Dec 31.

本文引用的文献

1
Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.人细胞色素P450 3A4对咪达唑仑区域特异性氧化的结构基础。
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):486-491. doi: 10.1073/pnas.1616198114. Epub 2016 Dec 28.
2
DOCK 6: Impact of new features and current docking performance.DOCK 6:新特性及当前对接性能的影响
J Comput Chem. 2015 Jun 5;36(15):1132-56. doi: 10.1002/jcc.23905.
3
Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.受分子动力学模拟启发,细胞色素P450 3A4活性位点突变体催化卡马西平环氧化反应中的协同作用与底物抑制作用
Biochemistry. 2015 Jan 27;54(3):711-21. doi: 10.1021/bi5011656. Epub 2015 Jan 15.
4
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals.参与外源性和天然化学物质代谢的人类氧化还原酶和细胞色素P450酶的综述。
Chem Res Toxicol. 2015 Jan 20;28(1):38-42. doi: 10.1021/tx500444e. Epub 2014 Dec 19.
5
Identification of CYP3A7 for glyburide metabolism in human fetal livers.人胎儿肝脏中格列本脲代谢的CYP3A7鉴定。
Biochem Pharmacol. 2014 Dec 15;92(4):690-700. doi: 10.1016/j.bcp.2014.09.025. Epub 2014 Oct 22.
6
The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.修订后的人类肝脏细胞色素P450“图谱”:使用靶向定量蛋白质组学对CYP4F和CYP3A酶进行绝对蛋白质定量
Drug Metab Dispos. 2014 Aug;42(8):1241-51. doi: 10.1124/dmd.114.058040. Epub 2014 May 9.
7
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.SWISS-MODEL:利用进化信息进行蛋白质三级和四级结构建模。
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8. doi: 10.1093/nar/gku340. Epub 2014 Apr 29.
8
Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.预测CYP3A代谢药物的“儿童首剂剂量”:比例缩放方法的评估及对儿童期CYP3A7 - CYP3A4转换的见解
J Clin Pharmacol. 2014 Sep;54(9):1006-15. doi: 10.1002/jcph.294. Epub 2014 Mar 28.
9
CYP3A4 activity reduces the cytotoxic effects of okadaic acid in HepaRG cells.细胞色素P450 3A4(CYP3A4)的活性可降低冈田酸对HepaRG细胞的细胞毒性作用。
Arch Toxicol. 2014 Aug;88(8):1519-26. doi: 10.1007/s00204-014-1206-x. Epub 2014 Feb 7.
10
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.细胞色素 P450 酶在药物代谢中的作用:基因表达调控、酶活性及遗传变异的影响。
Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16.

深入探究 CYP3A 睾酮代谢:CYP3A4/5 和 CYP3A7 的动力学、区域选择性和立体选择性差异。

Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.

机构信息

Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas (S.E.K., J.N.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (L.W.H., Q.M.); and The University of Kansas Liver Center, Kansas City, Kansas (J.N.L.).

Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas (S.E.K., J.N.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (L.W.H., Q.M.); and The University of Kansas Liver Center, Kansas City, Kansas (J.N.L.)

出版信息

Drug Metab Dispos. 2017 Dec;45(12):1266-1275. doi: 10.1124/dmd.117.078055. Epub 2017 Oct 6.

DOI:10.1124/dmd.117.078055
PMID:28986474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5697443/
Abstract

The metabolism of testosterone to 6-hydroxytestosterone (6-OH-T) is a commonly used assay to evaluate human CYP3A enzyme activities. However, previous reports have indicated that CYP3A7 also produces 2-hydroxytestosterone (2-OH-T) and that a 2-OH-T/6-OH-T ratio may be a unique endogenous biomarker of the activity of the enzyme. Until now, the full metabolite and kinetic profile for testosterone hydroxylation by CYP3A7 has not been fully examined. To this end, we performed a complete kinetic analysis of the 6-OH-T, 2-OH-T, and 2-hydroxytestosterone metabolites for recombinant Supersome CYP3A4, CYP3A5, and CYP3A7 enzymes and monitored metabolism in fetal and adult human liver microsomes for comparison. In general, a decrease in the velocity of the reaction was observed between CYP3A4 and the two other enzymes, with CYP3A7 showing the lowest metabolic capacity. Interestingly, we found that the 2-OH-T/6-OH-T ratio varied with substrate concentration when testosterone was incubated with CYP3A7, suggesting that this ratio would likely not function well as a biomarker for CYP3A7 activity. In silico docking studies revealed at least two different binding modes for testosterone between CYP3A4 and CYP3A7. In CYP3A4, the most energetically favorable docking mode places testosterone in a position with the methyl groups directed toward the heme iron, which is more favorable for oxidation at C6, whereas for CYP3A7 the testosterone methyl groups are positioned away from the heme, which is more favorable for an oxidation event at C2 In conclusion, our data indicate an alternative binding mode for testosterone in CYP3A7 that favors the 2-hydroxylation, suggesting significant structural differences in its active site compared with CYP3A4/5.

摘要

睾酮代谢为 6-羟睾酮(6-OH-T)是评估人 CYP3A 酶活性的常用方法。然而,先前的报告表明,CYP3A7 也产生 2-羟睾酮(2-OH-T),并且 2-OH-T/6-OH-T 比值可能是该酶活性的独特内源性生物标志物。到目前为止,CYP3A7 对睾酮羟化的完整代谢物和动力学特征尚未得到充分研究。为此,我们对重组 Supersome CYP3A4、CYP3A5 和 CYP3A7 酶的 6-OH-T、2-OH-T 和 2-羟睾酮代谢物进行了全面的动力学分析,并监测了胎儿和成人肝微粒体中的代谢情况以进行比较。一般来说,与另外两种酶相比,CYP3A4 的反应速度降低,CYP3A7 的代谢能力最低。有趣的是,我们发现当睾酮与 CYP3A7 孵育时,2-OH-T/6-OH-T 比值随底物浓度而变化,这表明该比值不太可能作为 CYP3A7 活性的生物标志物。计算机对接研究揭示了 CYP3A4 和 CYP3A7 之间睾酮的至少两种不同结合模式。在 CYP3A4 中,最具能量优势的对接模式将睾酮置于甲基基团朝向血红素铁的位置,这有利于 C6 的氧化,而对于 CYP3A7,睾酮的甲基基团远离血红素,这有利于 C2 的氧化事件。总之,我们的数据表明 CYP3A7 中睾酮的替代结合模式有利于 2-羟化,表明与 CYP3A4/5 相比,其活性位点存在显著的结构差异。